What is the estimated absolute risk difference between Digoxin and Placebo for all-cause mortality in CKD class 3a/b?
The estimated absolute risk difference between Digoxin and Placebo for all-cause mortality in CKD class 3a/b is overall (from 46 fewer to 18 more). This has been downgraded by 1 increment due to indirectness as a compound outcome was reported rather than numbers of admissions.